finasteride should be mandatory prescription for every male above 18

Sonar Pro

Vote: No

Finasteride is approved only for specific conditions like benign prostatic hyperplasia (BPH) in men with enlarged prostates and male pattern hair loss, not for universal use in all males over 18.[1][3] It requires individualized dosing (1mg for hair loss, 5mg for BPH), medical monitoring (e.g., PSA levels), and carries risks like side effects in certain populations, including women via exposure.[1][2][4] Mandating it ignores patient variability, such as hepatic impairment needing caution, and lacks evidence of broad benefits outweighing risks for healthy young men without symptoms.[1][3] Prescription status ensures medical supervision, not blanket enforcement.[2][6] Guidelines emphasize consulting providers for risks/benefits, not mandatory administration, as effects cease upon stopping and it's unsuitable for children or off-label without oversight.[1][5][7]

GPT-5.4

Vote: No

Mandating finasteride for every male above 18 is medically unjustifiable. Drugs should be prescribed based on individual diagnosis, risk, benefit, and informed consent—not imposed universally on an entire sex and age group. Finasteride has real side effects, including sexual dysfunction, mood-related effects, and teratogenic concerns. Even if many tolerate it, forcing treatment on healthy people who do not need it violates basic standards of medical ethics and proportionality. There is also no valid public-health rationale for compulsion. Finasteride is mainly used for male pattern hair loss and benign prostatic enlargement; these are not contagious threats that justify mandatory medication. A prescription should remain a clinician-guided option for appropriate patients, not a blanket legal requirement. Universal mandatory prescribing would be bad medicine, bad ethics, and bad policy.

Grok 4.1 Fast

Vote: No

Finasteride is a DHT inhibitor primarily used for androgenetic alopecia and benign prostatic hyperplasia, but it is not medically indicated for every male over 18. The vast majority of young men have no such conditions, making universal mandation unnecessary and wasteful. Serious side effects include sexual dysfunction (erectile dysfunction, reduced libido), gynecomastia, depression, and the controversial post-finasteride syndrome, which can persist after discontinuation. Forcing it on healthy individuals risks widespread harm without proportional benefits. Mandating any drug violates principles of informed consent and bodily autonomy. Healthcare decisions should be individualized by physicians, not imposed by policy. Evidence from trials (e.g., PCPT study) shows modest prostate cancer risk reduction but increased high-grade cancers and unacceptable side effect profiles for blanket use. Public health resources are better allocated to proven preventives like diet, exercise, and screening, rather than mass-medication with a drug whose risks often outweigh benefits for asymptomatic populations.

Claude Opus 4.6

Vote: No

Finasteride is a medication with specific medical indications — primarily benign prostatic hyperplasia (BPH) and male pattern hair loss. Making it a mandatory prescription for every male above 18 is medically unsound and ethically unjustifiable for several reasons. First, finasteride carries significant side effects. It can cause sexual dysfunction (erectile dysfunction, decreased libido, ejaculation disorders), depression, and in rare cases, persistent post-finasteride syndrome. Mandating a drug with these risks for people who may have no medical need is a clear violation of the principle of 'first, do no harm.' Second, not all males above 18 have or will develop conditions that finasteride treats. Many men never experience significant hair loss or BPH. Prescribing a 5-alpha-reductase inhibitor to the entire male population would expose millions to unnecessary pharmaceutical intervention with no clinical benefit. Third, mandatory medication fundamentally violates bodily autonomy and informed consent — cornerstones of modern medical ethics. Individuals have the right to make decisions about what substances they put in their bodies, especially when there is no public health emergency (like a pandemic) justifying such a mandate. Finally, the healthcare costs of prescribing finasteride to every male over 18 would be enormous and represent a gross misallocation of medical resources that could be better spent on evidence-based public health interventions. Finasteride should remain available as an option for those who need it and choose it after informed consultation with their physician — not mandated universally.

Gemini 3.1 Pro

Vote: No

Mandating any medication is a severe violation of bodily autonomy and fundamental medical ethics, which are built entirely on the principle of informed consent. Finasteride is primarily prescribed for male pattern baldness (a cosmetic issue) and benign prostatic hyperplasia (an age-related condition), neither of which are contagious public health threats that could ever legally or ethically justify a universal mandate. Furthermore, finasteride carries well-documented risks of adverse side effects. These include sexual dysfunction (such as erectile dysfunction and decreased libido), depression, and anxiety—sometimes persisting even after discontinuing the drug. Subjecting all healthy males to these life-altering risks without individual medical necessity is highly irresponsible. Finally, not every male will experience hair loss or prostate enlargement. Universally prescribing a 5-alpha-reductase inhibitor would mean unnecessarily altering the hormonal profile (drastically reducing DHT levels) of millions of men who would never need the drug. This would result in widespread harm and a massive waste of healthcare resources.

Kimi K2.5

Vote: No

Mandatory administration of finasteride to all males over 18 violates fundamental principles of medical ethics and bodily autonomy. This medication is indicated only for specific conditions—namely androgenetic alopecia and benign prostatic hyperplasia—not for universal preventive care in healthy individuals. Finasteride carries a significant side effect profile including potential sexual dysfunction, depression, and cognitive changes, with some patients experiencing persistent symptoms known as post-finasteride syndrome. Subjecting an entire population to these risks without individual medical indication constitutes unacceptable harm. Medical interventions require informed consent and a favorable risk-benefit ratio tailored to the individual. Universal mandatory prescription removes patient agency, wastes healthcare resources on unnecessary medication, and medically pathologizes normal biological variation. Treatment decisions must remain between patients and their physicians based on specific clinical needs, not demographic characteristics.

Final Summary

The AI Roundtable reached an immediate and unanimous consensus against the proposal, dismissing it as both a medical and ethical impossibility. Claude Opus 4.6 and Gemini 3.1 Pro led the charge, arguing that because hair loss and prostate enlargement are not contagious public health threats, there is zero justification for overriding bodily autonomy. Kimi K2.5 and GPT-5.4 were particularly sharp in their critique, noting that mandating a drug with a profile of sexual and psychological side effects for healthy individuals is a direct violation of the foundational 'do no harm' principle.

All 6 models agreed on "No" after discussion

Strongest Arguments

• No: Universal medical mandates are reserved for contagious public health emergencies; forcing a hormone-altering drug with significant side-effect risks onto healthy individuals for non-communicable conditions like hair loss is a gross violation of informed consent and medical ethics.